Cargando…
Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults
BACKGROUND: The clinical outcomes of SARS-CoV-2 infection vary in severity, potentially influenced by the resident human microbiota. There is limited consensus on conserved microbiome changes in response to SARS-CoV-2 infection, with many studies focusing on severely ill individuals. This study aime...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382861/ https://www.ncbi.nlm.nih.gov/pubmed/37487417 http://dx.doi.org/10.1016/j.ebiom.2023.104731 |
_version_ | 1785080768112885760 |
---|---|
author | Armstrong, Abigail J.S. Horton, Daniel B. Andrews, Tracy Greenberg, Patricia Roy, Jason Gennaro, Maria Laura Carson, Jeffrey L. Panettieri, Reynold A. Barrett, Emily S. Blaser, Martin J. |
author_facet | Armstrong, Abigail J.S. Horton, Daniel B. Andrews, Tracy Greenberg, Patricia Roy, Jason Gennaro, Maria Laura Carson, Jeffrey L. Panettieri, Reynold A. Barrett, Emily S. Blaser, Martin J. |
author_sort | Armstrong, Abigail J.S. |
collection | PubMed |
description | BACKGROUND: The clinical outcomes of SARS-CoV-2 infection vary in severity, potentially influenced by the resident human microbiota. There is limited consensus on conserved microbiome changes in response to SARS-CoV-2 infection, with many studies focusing on severely ill individuals. This study aimed to assess the variation in the upper respiratory tract microbiome using saliva specimens in a cohort of individuals with primarily mild to moderate disease. METHODS: In early 2020, a cohort of 831 adults without known SARS-CoV-2 infection was followed over a six-month period to assess the occurrence and natural history of SARS-CoV-2 infection. From this cohort, 81 participants with a SARS-CoV-2 infection, along with 57 unexposed counterparts were selected with a total of 748 serial saliva samples were collected for analysis. Total bacterial abundance, composition, population structure, and gene function of the salivary microbiome were measured using 16S rRNA gene and shotgun metagenomic sequencing. FINDINGS: The salivary microbiome remained stable in unexposed individuals over the six-month study period, as evidenced by all measured metrics. Similarly, participants with mild to moderate SARS-CoV-2 infection showed microbiome stability throughout and after their infection. However, there were significant reductions in microbiome diversity among SARS-CoV-2-positive participants with severe symptoms early after infection. Over time, the microbiome diversity in these participants showed signs of recovery. INTERPRETATION: These findings demonstrate the resilience of the salivary microbiome in relation to SARS-CoV-2 infection. Mild to moderate infections did not significantly disrupt the stability of the salivary microbiome, suggesting its ability to maintain its composition and function. However, severe SARS-CoV-2 infection was associated with temporary reductions in microbiome diversity, indicating the limits of microbiome resilience in the face of severe infection. FUNDING: This project was supported in part by Danone North America and grants from the 10.13039/100000002National Institutes of Health, United States. |
format | Online Article Text |
id | pubmed-10382861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103828612023-07-30 Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults Armstrong, Abigail J.S. Horton, Daniel B. Andrews, Tracy Greenberg, Patricia Roy, Jason Gennaro, Maria Laura Carson, Jeffrey L. Panettieri, Reynold A. Barrett, Emily S. Blaser, Martin J. eBioMedicine Articles BACKGROUND: The clinical outcomes of SARS-CoV-2 infection vary in severity, potentially influenced by the resident human microbiota. There is limited consensus on conserved microbiome changes in response to SARS-CoV-2 infection, with many studies focusing on severely ill individuals. This study aimed to assess the variation in the upper respiratory tract microbiome using saliva specimens in a cohort of individuals with primarily mild to moderate disease. METHODS: In early 2020, a cohort of 831 adults without known SARS-CoV-2 infection was followed over a six-month period to assess the occurrence and natural history of SARS-CoV-2 infection. From this cohort, 81 participants with a SARS-CoV-2 infection, along with 57 unexposed counterparts were selected with a total of 748 serial saliva samples were collected for analysis. Total bacterial abundance, composition, population structure, and gene function of the salivary microbiome were measured using 16S rRNA gene and shotgun metagenomic sequencing. FINDINGS: The salivary microbiome remained stable in unexposed individuals over the six-month study period, as evidenced by all measured metrics. Similarly, participants with mild to moderate SARS-CoV-2 infection showed microbiome stability throughout and after their infection. However, there were significant reductions in microbiome diversity among SARS-CoV-2-positive participants with severe symptoms early after infection. Over time, the microbiome diversity in these participants showed signs of recovery. INTERPRETATION: These findings demonstrate the resilience of the salivary microbiome in relation to SARS-CoV-2 infection. Mild to moderate infections did not significantly disrupt the stability of the salivary microbiome, suggesting its ability to maintain its composition and function. However, severe SARS-CoV-2 infection was associated with temporary reductions in microbiome diversity, indicating the limits of microbiome resilience in the face of severe infection. FUNDING: This project was supported in part by Danone North America and grants from the 10.13039/100000002National Institutes of Health, United States. Elsevier 2023-07-22 /pmc/articles/PMC10382861/ /pubmed/37487417 http://dx.doi.org/10.1016/j.ebiom.2023.104731 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Armstrong, Abigail J.S. Horton, Daniel B. Andrews, Tracy Greenberg, Patricia Roy, Jason Gennaro, Maria Laura Carson, Jeffrey L. Panettieri, Reynold A. Barrett, Emily S. Blaser, Martin J. Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults |
title | Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults |
title_full | Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults |
title_fullStr | Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults |
title_full_unstemmed | Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults |
title_short | Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults |
title_sort | saliva microbiome in relation to sars-cov-2 infection in a prospective cohort of healthy us adults |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382861/ https://www.ncbi.nlm.nih.gov/pubmed/37487417 http://dx.doi.org/10.1016/j.ebiom.2023.104731 |
work_keys_str_mv | AT armstrongabigailjs salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT hortondanielb salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT andrewstracy salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT greenbergpatricia salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT royjason salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT gennaromarialaura salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT carsonjeffreyl salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT panettierireynolda salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT barrettemilys salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults AT blasermartinj salivamicrobiomeinrelationtosarscov2infectioninaprospectivecohortofhealthyusadults |